Biotech developing cell-based therapeutics to restore vision.
| Date | Round | Amount |
|---|---|---|
| Jul 2023 | Series A UK biotech Tenpoint Therapeutics raised a $70M Series A (British Patient Capital, F-Prime, Sofinnova). | $70M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.